A previous study reported that MYL5 expression is reduced in multiple cancers, including breast cancer, colorectal cancer, esophageal cancer, gastric cancer, head and neck cancer, and leukemia, compared to corresponding normal tissues (Lv, 2023). Here, MYL5 is linked to gastric cancer.